HB 93 – Require Naloxone Scripts with Opioid Scripts

Primary House Sponsors: Rep. Wayne Sasser (R-Cabarrus, Rowan, Stanly); Rep. Chris Humphrey (R-Lenoir, Pitt); Rep. Timothy Moffitt (R-Henderson); Rep. Gale Adcock (D-Wake)


This bill requires practitioners to co-prescribe an opioid antagonist when one or more of the following conditions are present:

  • The prescription dosage is 50 or more morphine milligram equivalents of an opioid medication per day.
  • A Schedule II controlled substance is prescribed concurrently with a prescription for benzodiazepine.
  • The patient present with an increase risk for overdose, as evidence by, but not limited to (1) a patient with a history of overdose; (2) a patient with a history of substance use disorder, or (3) a patient at risk for returning to a high dosage of a Schedule II controlled substance to which the patient is no longer tolerant.

This bill also requires practitioners to provide education on overdose prevent and opioid antagonist use to all patients receiving prescriptions pursuant to the new requirements or to the patient’s parent, guardian, or person standing in loco parentis.

The failure to comply with the bill’s requirements would subject practitioners to potential administrative sanctions as deemed appropriate by their licensing board.


Filed – 2/16/2021

Referred to the following House Committees on 2/17/2021:



-Rules, Calendar, Operations

Re-referred to House Health Committee on 3/10/2021